OOO Smartpharmo Pharmaceutical Import Profile — Uzbekistan (DGFT 2022–2026)

Name: OOO Smartpharmo Pharmaceutical Import Records from India — 3 Products, $700.0K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

OOO Smartpharmo — Pharmaceutical Importer Profile (2026) | 3 Products, $700.0K Trade | TransData Nexus

OOO Smartpharmo

Pharmaceutical Importer · Uzbekistan · Antihistamines & Allergy Focus · $700.0K Total Trade · DGFT Verified

OOO Smartpharmo is a pharmaceutical importer based in Uzbekistan with a total trade value of $700.0K across 3 products in 3 therapeutic categories. Based on 14 verified import shipments from Indian Customs (DGFT) records, OOO Smartpharmo is the #1 buyer in 2 products including Chlorpheniramine, Ranitidine. OOO Smartpharmo sources from 1 verified Indian supplier, with Combitic Global Caplet Private Limited accounting for 100.0% of imports.

OOO Smartpharmo — Import Portfolio & Supplier Network

OOO Smartpharmo import network — 3 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to OOO Smartpharmo?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Combitic Global Caplet Private Limited	$648.7K	19	100.0%

OOO Smartpharmo sources from 1 verified Indian supplier across 6 distinct formulations. The sourcing is highly concentrated — Combitic Global Caplet Private Limited accounts for 100.0% of total imports, indicating a strategic single-source relationship.

Formulation	Value	Ships
Paracetamol, chlorpheniramine maleate	$246.7K	5
Ranitidine hydrochloride tablets IP	$157.5K	5
Diclofenac diethylamine, linseed oil	$133.6K	4
Cefixime tablet 400MG (letfixim tablet	$80.1K	2
Cefixime dispersible tablet 200 MG	$22.7K	1
Sildenafil citrate and dapoxetine	$8.1K	2

Import Portfolio — Top 3 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Chlorpheniramine	Antihistamines & Allergy	$250.0K	5	0.5%	1
2	Ranitidine	Gastrointestinal	$250.0K	5	2.0%	1
3	Diclofenac	Analgesics & Antipyretics	$200.0K	4	0.1%	14

OOO Smartpharmo imports 3 pharmaceutical products across 3 categories into Uzbekistan totaling $700.0K. The company is the #1 buyer for 2 products: Chlorpheniramine, Ranitidine.

OOO Smartpharmo — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

OOO Smartpharmo is a pharmaceutical importer based in Tashkent, Uzbekistan, specializing in the procurement of finished pharmaceutical formulations. The company operates as a buyer, sourcing a range of pharmaceutical products from international suppliers to meet the domestic demand in Uzbekistan. While specific details about its parent company are not publicly available, OOO Smartpharmo plays a significant role in the Uzbek pharmaceutical distribution network by ensuring the availability of essential medications.

The company's import activities are primarily focused on finished pharmaceutical formulations, including tablets, capsules, syrups, and injections. This emphasis indicates a strategic approach to providing ready-to-use medications that are immediately available for distribution within the country. By importing these finished products, OOO Smartpharmo contributes to the efficiency of the pharmaceutical supply chain in Uzbekistan, reducing the need for local manufacturing and expediting the availability of critical drugs to healthcare providers and patients.

2Distribution Network

OOO Smartpharmo's distribution network is centered in Tashkent, the capital city of Uzbekistan, where its headquarters are located. The company imports pharmaceutical products from India, with a total import value of $700,000 USD across 14 shipments. The primary supplier is Combitic Global Caplet Private Limited, accounting for 100% of the shipments. While specific details about warehouse locations and logistics capabilities are not publicly disclosed, the company's operations suggest a focus on efficient distribution within Uzbekistan. The reliance on a single supplier indicates a streamlined logistics process, potentially reducing complexities in inventory management and distribution.

3Industry Role

In Uzbekistan's pharmaceutical supply chain, OOO Smartpharmo functions as a pharmaceutical importer and distributor. By sourcing finished pharmaceutical formulations from international suppliers, the company ensures the availability of essential medications in the domestic market. This role is crucial in meeting the healthcare needs of the population, especially for drugs that are not produced locally. OOO Smartpharmo's activities support the healthcare infrastructure by providing timely access to a variety of pharmaceutical products, thereby contributing to the overall health and well-being of the community.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — OOO Smartpharmo

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

OOO Smartpharmo's sourcing strategy exhibits a high degree of concentration, with all 14 shipments originating from a single supplier, Combitic Global Caplet Private Limited. This single-source dependency could pose risks related to supply chain disruptions, such as production delays or quality control issues at the supplier's end. However, the consistent volume of imports and the exclusive relationship suggest a stable and reliable partnership. The supplier's ability to meet OOO Smartpharmo's demands without the need for additional suppliers indicates a strong and dependable sourcing arrangement. Nonetheless, the lack of diversification in the supplier base may limit the company's flexibility in responding to market changes or negotiating better terms.

2Supply Chain Resilience

The resilience of OOO Smartpharmo's supply chain is closely tied to the stability and reliability of Combitic Global Caplet Private Limited. With all imports sourced from this single supplier, any disruptions in their production or logistics could directly impact OOO Smartpharmo's ability to meet domestic demand. The absence of backup suppliers and limited formulation diversity further heighten this vulnerability. Additionally, the reliance on a single shipping route exposes the company to potential logistical challenges, such as transportation delays or geopolitical issues affecting trade routes. Ensuring that Combitic Global Caplet Private Limited adheres to international regulatory standards and maintains consistent product quality is essential for mitigating these risks.

Importing Pharmaceuticals into Uzbekistan — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Uzbekistan

1Regulatory Authority & Framework

The pharmaceutical industry in Uzbekistan is regulated by the Ministry of Health, which oversees the registration, import, and distribution of pharmaceutical products. Key legislation governing pharmaceutical imports includes the Law on Medicines and Pharmaceutical Activities, which outlines the procedures for state registration and quality control of medicines. The marketing authorization pathway for Indian generics involves obtaining state registration from the Ministry of Health, which may require submission of product dossiers, clinical trial data, and compliance with Good Manufacturing Practice (GMP) standards. Additionally, Uzbekistan recognizes marketing authorizations from certain countries and organizations, facilitating a streamlined registration process for products approved in these jurisdictions.

2Import Licensing & GMP

Import licensing in Uzbekistan requires pharmaceutical companies to obtain state registration for each product they intend to import. This process involves submitting detailed product information, including manufacturing details, quality control measures, and clinical data, to the Ministry of Health. Uzbekistan recognizes GMP certificates from the European Union, World Health Organization (WHO), and the Pharmaceutical Inspection Co-operation Scheme (PIC/S), which can expedite the registration process for foreign manufacturers. Wholesale distribution authorization is also mandatory, ensuring that companies comply with local regulations regarding storage, handling, and distribution of pharmaceutical products.

OOO Smartpharmo — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

OOO Smartpharmo's product strategy focuses on importing finished pharmaceutical formulations in the therapeutic categories of Antihistamines & Allergy, Gastrointestinal, and Analgesics & Antipyretics. This selection aligns with common health concerns in Uzbekistan, addressing conditions such as allergies, digestive disorders, and pain management. The market demand for these products is driven by the prevalence of these health issues among the population, necessitating a steady supply of effective medications. By concentrating on these therapeutic areas, OOO Smartpharmo aims to meet critical healthcare needs and maintain a competitive edge in the pharmaceutical market.

2Sourcing Profile

OOO Smartpharmo's sourcing strategy is centered on importing generic drugs from India, focusing on finished pharmaceutical formulations. The company's preference for specific formulations, such as Chlorpheniramine, Ranitidine, and Diclofenac, indicates a targeted approach to meet the therapeutic needs of the Uzbek market. India's established pharmaceutical manufacturing capabilities and adherence to international quality standards make it a suitable partner for OOO Smartpharmo's procurement needs. This sourcing profile enables the company to offer a range of affordable and effective medications to the Uzbek population.

3Market Positioning

Seller's Guide — How to Become a Supplier to OOO Smartpharmo

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to collaborate with OOO Smartpharmo, especially given the company's concentrated sourcing strategy. By offering competitive pricing, reliable delivery schedules, and adherence to quality standards, Indian exporters can position themselves as viable partners. Diversifying OOO Smartpharmo's supplier base could enhance the company's supply chain resilience and provide access to a broader range of pharmaceutical products. Identifying gaps in the current sourcing strategy, such as unmet therapeutic needs or emerging market trends, can further inform potential partnerships.

2Requirements & Qualifications

Indian exporters seeking to supply OOO Smartpharmo and the Uzbekistan market must ensure compliance with Uzbekistan's regulatory requirements. This includes obtaining state registration for each product, adhering to Good Manufacturing Practice (GMP) standards recognized by Uzbekistan, and ensuring that products meet quality control measures mandated by the Ministry of Health. Additionally, labeling must be in the Uzbek language, and products must comply with serialization mandates to facilitate traceability.

3How to Approach

Frequently Asked Questions — OOO Smartpharmo

What products does OOO Smartpharmo import from India?

OOO Smartpharmo imports 3 pharmaceutical products across 3 categories. Top imports: Chlorpheniramine ($250.0K), Ranitidine ($250.0K), Diclofenac ($200.0K).

Who supplies pharmaceuticals to OOO Smartpharmo from India?

OOO Smartpharmo sources from 1 verified Indian suppliers. The primary supplier is Combitic Global Caplet Private Limited (100.0% of imports, $648.7K).

What is OOO Smartpharmo's total pharmaceutical import value?

OOO Smartpharmo's total pharmaceutical import value from India is $700.0K, based on 14 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does OOO Smartpharmo focus on?

OOO Smartpharmo imports across 3 categories. The largest: Antihistamines & Allergy (35.7%), Gastrointestinal (35.7%), Analgesics & Antipyretics (28.6%).

Get Full OOO Smartpharmo Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.